HBI0101 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HBI0101 CAR-T therapy, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma [Phase 1]